Case Type: Mergers & Acquisitions

Continental Resources, Inc. (CLR), relating to its proposed merger with Omega Acquisition, Inc. Under the terms of the tender offer, CLR shareholders are expected to receive $74.28 in cash per share they own.

AVEO Pharmaceuticals, Inc. (AVEO), relating to its proposed acquisition by LG Chem, Ltd. Under the terms of the agreement, AVEO shareholders are expected to receive $15.00 in cash per share they own.

Archaea Energy Inc. (LFG), relating to its proposed acquisition by BP plc. Under the terms of the agreement, LFG shareholders are expected to receive $26.00 in cash per share they own.

Akouos, Inc. (AKUS), relating to its proposed acquisition by Eli Lilly and Company. Under the terms of the tender offer, AKUS shareholders are expected to receive $12.50 in cash plus one CVR of up to $3.00 per share they own.

Myovant Sciences Ltd. (MYOV), relating to its proposed acquisition by Sumitovant Bopharma Ltd. and Sumitomo Pharma Co., Ltd. Under the terms of the agreement, MYOV shareholders are expected to receive $27.00 in cash per share they own.

KnowBe4, Inc. (KNBE), relating to its proposed acquisition by Vista Equity Partners. Under the terms of the agreement, KNBE shareholders are expected to receive $24.90 in cash per share they own.

HV Bancorp, Inc. (HVBC), relating to its proposed sale to Citizens Financial Services, Inc. Under the terms of the agreement, HVBC shareholders are expected to receive either 0.400 shares of Citizens or $30.50 in cash per share they own.

Ayala Pharmaceuticals, Inc. (AYLA), relating to its proposed merger with Advaxis, Inc. Under the terms of the agreement, AYLA shareholders are expected to own approximately 62.5% of the combined company.

ForgeRock, Inc. (FORG), relating to its proposed acquisition by Thoma Bravo. Under the terms of the agreement, FORG shareholders are expected to receive $23.25 in cash per share they own.

IMARA Inc. (IMRA), relating to its proposed merger with Enliven Therapeutics, Inc. Under the terms of the agreement, IMARA shareholders are expected to own approximately 16% of the combined company.